Hypertension and Heart Failure Drugs such as ?-blockers, angiotensin-converting enzyme inhibitiors, angiotensin receptor blockers, aldosterone receptor blockers, hydralazine and nitrates, which have shown mortality benefit in CHF and exert antihypertensive effects, are used as first-line agents to control HTN in CHF.
This report aims to provide a comprehensive presentation of the global market for Hypertension and Heart Failure Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hypertension and Heart Failure Drugs. This report contains market size and forecasts of Hypertension and Heart Failure Drugs in global, including the following market information:
Global Hypertension and Heart Failure Drugs Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Hypertension and Heart Failure Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Diuretics Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Hypertension and Heart Failure Drugs include Menarini Group, Johnson & Johnson, Lupin, Boehringer Ingelheim, Novartis, Merck & Co, AstraZeneca, Pfizer, Inc and Sanofi SA, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hypertension and Heart Failure Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hypertension and Heart Failure Drugs Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Hypertension and Heart Failure Drugs Market Segment Percentages, by Type, 2022 (%)
Diuretics
Beta Blockers
Ace Inhibitors
Alpha Blockers
Others
Global Hypertension and Heart Failure Drugs Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Hypertension and Heart Failure Drugs Market Segment Percentages, by Application, 2022 (%)
Men
Women
Global Hypertension and Heart Failure Drugs Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Hypertension and Heart Failure Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hypertension and Heart Failure Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Hypertension and Heart Failure Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Menarini Group
Johnson & Johnson
Lupin
Boehringer Ingelheim
Novartis
Merck & Co
AstraZeneca
Pfizer, Inc
Sanofi SA
Dr. Reddy's Laboratories
Daiichi Sankyo Company Limited
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hypertension and Heart Failure Drugs, market overview.
Chapter 2: Global Hypertension and Heart Failure Drugs market size in revenue.
Chapter 3: Detailed analysis of Hypertension and Heart Failure Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hypertension and Heart Failure Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Hypertension and Heart Failure Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hypertension and Heart Failure Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hypertension and Heart Failure Drugs Overall Market Size
2.1 Global Hypertension and Heart Failure Drugs Market Size: 2022 VS 2032
2.2 Global Hypertension and Heart Failure Drugs Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hypertension and Heart Failure Drugs Players in Global Market
3.2 Top Global Hypertension and Heart Failure Drugs Companies Ranked by Revenue
3.3 Global Hypertension and Heart Failure Drugs Revenue by Companies
3.4 Top 3 and Top 5 Hypertension and Heart Failure Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Hypertension and Heart Failure Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hypertension and Heart Failure Drugs Players in Global Market
3.6.1 List of Global Tier 1 Hypertension and Heart Failure Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Hypertension and Heart Failure Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Hypertension and Heart Failure Drugs Market Size Markets, 2022 & 2032
4.1.2 Diuretics
4.1.3 Beta Blockers
4.1.4 Ace Inhibitors
4.1.5 Alpha Blockers
4.1.6 Others
4.2 By Type - Global Hypertension and Heart Failure Drugs Revenue & Forecasts
4.2.1 By Type - Global Hypertension and Heart Failure Drugs Revenue, 2018-2023
4.2.2 By Type - Global Hypertension and Heart Failure Drugs Revenue, 2024-2032
4.2.3 By Type - Global Hypertension and Heart Failure Drugs Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hypertension and Heart Failure Drugs Market Size, 2022 & 2032
5.1.2 Men
5.1.3 Women
5.2 By Application - Global Hypertension and Heart Failure Drugs Revenue & Forecasts
5.2.1 By Application - Global Hypertension and Heart Failure Drugs Revenue, 2018-2023
5.2.2 By Application - Global Hypertension and Heart Failure Drugs Revenue, 2024-2032
5.2.3 By Application - Global Hypertension and Heart Failure Drugs Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Hypertension and Heart Failure Drugs Market Size, 2022 & 2032
6.2 By Region - Global Hypertension and Heart Failure Drugs Revenue & Forecasts
6.2.1 By Region - Global Hypertension and Heart Failure Drugs Revenue, 2018-2023
6.2.2 By Region - Global Hypertension and Heart Failure Drugs Revenue, 2024-2032
6.2.3 By Region - Global Hypertension and Heart Failure Drugs Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Hypertension and Heart Failure Drugs Revenue, 2018-2032
6.3.2 US Hypertension and Heart Failure Drugs Market Size, 2018-2032
6.3.3 Canada Hypertension and Heart Failure Drugs Market Size, 2018-2032
6.3.4 Mexico Hypertension and Heart Failure Drugs Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Hypertension and Heart Failure Drugs Revenue, 2018-2032
6.4.2 Germany Hypertension and Heart Failure Drugs Market Size, 2018-2032
6.4.3 France Hypertension and Heart Failure Drugs Market Size, 2018-2032
6.4.4 U.K. Hypertension and Heart Failure Drugs Market Size, 2018-2032
6.4.5 Italy Hypertension and Heart Failure Drugs Market Size, 2018-2032
6.4.6 Russia Hypertension and Heart Failure Drugs Market Size, 2018-2032
6.4.7 Nordic Countries Hypertension and Heart Failure Drugs Market Size, 2018-2032
6.4.8 Benelux Hypertension and Heart Failure Drugs Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Hypertension and Heart Failure Drugs Revenue, 2018-2032
6.5.2 China Hypertension and Heart Failure Drugs Market Size, 2018-2032
6.5.3 Japan Hypertension and Heart Failure Drugs Market Size, 2018-2032
6.5.4 South Korea Hypertension and Heart Failure Drugs Market Size, 2018-2032
6.5.5 Southeast Asia Hypertension and Heart Failure Drugs Market Size, 2018-2032
6.5.6 India Hypertension and Heart Failure Drugs Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Hypertension and Heart Failure Drugs Revenue, 2018-2032
6.6.2 Brazil Hypertension and Heart Failure Drugs Market Size, 2018-2032
6.6.3 Argentina Hypertension and Heart Failure Drugs Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hypertension and Heart Failure Drugs Revenue, 2018-2032
6.7.2 Turkey Hypertension and Heart Failure Drugs Market Size, 2018-2032
6.7.3 Israel Hypertension and Heart Failure Drugs Market Size, 2018-2032
6.7.4 Saudi Arabia Hypertension and Heart Failure Drugs Market Size, 2018-2032
6.7.5 UAE Hypertension and Heart Failure Drugs Market Size, 2018-2032
7 Hypertension and Heart Failure Drugs Companies Profiles
7.1 Menarini Group
7.1.1 Menarini Group Company Summary
7.1.2 Menarini Group Business Overview
7.1.3 Menarini Group Hypertension and Heart Failure Drugs Major Product Offerings
7.1.4 Menarini Group Hypertension and Heart Failure Drugs Revenue in Global Market (2018-2023)
7.1.5 Menarini Group Key News & Latest Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Company Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Hypertension and Heart Failure Drugs Major Product Offerings
7.2.4 Johnson & Johnson Hypertension and Heart Failure Drugs Revenue in Global Market (2018-2023)
7.2.5 Johnson & Johnson Key News & Latest Developments
7.3 Lupin
7.3.1 Lupin Company Summary
7.3.2 Lupin Business Overview
7.3.3 Lupin Hypertension and Heart Failure Drugs Major Product Offerings
7.3.4 Lupin Hypertension and Heart Failure Drugs Revenue in Global Market (2018-2023)
7.3.5 Lupin Key News & Latest Developments
7.4 Boehringer Ingelheim
7.4.1 Boehringer Ingelheim Company Summary
7.4.2 Boehringer Ingelheim Business Overview
7.4.3 Boehringer Ingelheim Hypertension and Heart Failure Drugs Major Product Offerings
7.4.4 Boehringer Ingelheim Hypertension and Heart Failure Drugs Revenue in Global Market (2018-2023)
7.4.5 Boehringer Ingelheim Key News & Latest Developments
7.5 Novartis
7.5.1 Novartis Company Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Hypertension and Heart Failure Drugs Major Product Offerings
7.5.4 Novartis Hypertension and Heart Failure Drugs Revenue in Global Market (2018-2023)
7.5.5 Novartis Key News & Latest Developments
7.6 Merck & Co
7.6.1 Merck & Co Company Summary
7.6.2 Merck & Co Business Overview
7.6.3 Merck & Co Hypertension and Heart Failure Drugs Major Product Offerings
7.6.4 Merck & Co Hypertension and Heart Failure Drugs Revenue in Global Market (2018-2023)
7.6.5 Merck & Co Key News & Latest Developments
7.7 AstraZeneca
7.7.1 AstraZeneca Company Summary
7.7.2 AstraZeneca Business Overview
7.7.3 AstraZeneca Hypertension and Heart Failure Drugs Major Product Offerings
7.7.4 AstraZeneca Hypertension and Heart Failure Drugs Revenue in Global Market (2018-2023)
7.7.5 AstraZeneca Key News & Latest Developments
7.8 Pfizer, Inc
7.8.1 Pfizer, Inc Company Summary
7.8.2 Pfizer, Inc Business Overview
7.8.3 Pfizer, Inc Hypertension and Heart Failure Drugs Major Product Offerings
7.8.4 Pfizer, Inc Hypertension and Heart Failure Drugs Revenue in Global Market (2018-2023)
7.8.5 Pfizer, Inc Key News & Latest Developments
7.9 Sanofi SA
7.9.1 Sanofi SA Company Summary
7.9.2 Sanofi SA Business Overview
7.9.3 Sanofi SA Hypertension and Heart Failure Drugs Major Product Offerings
7.9.4 Sanofi SA Hypertension and Heart Failure Drugs Revenue in Global Market (2018-2023)
7.9.5 Sanofi SA Key News & Latest Developments
7.10 Dr. Reddy's Laboratories
7.10.1 Dr. Reddy's Laboratories Company Summary
7.10.2 Dr. Reddy's Laboratories Business Overview
7.10.3 Dr. Reddy's Laboratories Hypertension and Heart Failure Drugs Major Product Offerings
7.10.4 Dr. Reddy's Laboratories Hypertension and Heart Failure Drugs Revenue in Global Market (2018-2023)
7.10.5 Dr. Reddy's Laboratories Key News & Latest Developments
7.11 Daiichi Sankyo Company Limited
7.11.1 Daiichi Sankyo Company Limited Company Summary
7.11.2 Daiichi Sankyo Company Limited Business Overview
7.11.3 Daiichi Sankyo Company Limited Hypertension and Heart Failure Drugs Major Product Offerings
7.11.4 Daiichi Sankyo Company Limited Hypertension and Heart Failure Drugs Revenue in Global Market (2018-2023)
7.11.5 Daiichi Sankyo Company Limited Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Hypertension and Heart Failure Drugs Market Opportunities & Trends in Global Market
Table 2. Hypertension and Heart Failure Drugs Market Drivers in Global Market
Table 3. Hypertension and Heart Failure Drugs Market Restraints in Global Market
Table 4. Key Players of Hypertension and Heart Failure Drugs in Global Market
Table 5. Top Hypertension and Heart Failure Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Hypertension and Heart Failure Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Hypertension and Heart Failure Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Hypertension and Heart Failure Drugs Product Type
Table 9. List of Global Tier 1 Hypertension and Heart Failure Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hypertension and Heart Failure Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Hypertension and Heart Failure Drugs Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Hypertension and Heart Failure Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Hypertension and Heart Failure Drugs Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Hypertension and Heart Failure Drugs Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Hypertension and Heart Failure Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Hypertension and Heart Failure Drugs Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Hypertension and Heart Failure Drugs Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Hypertension and Heart Failure Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Hypertension and Heart Failure Drugs Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Hypertension and Heart Failure Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Hypertension and Heart Failure Drugs Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Hypertension and Heart Failure Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Hypertension and Heart Failure Drugs Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Hypertension and Heart Failure Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Hypertension and Heart Failure Drugs Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Hypertension and Heart Failure Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Hypertension and Heart Failure Drugs Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Hypertension and Heart Failure Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Hypertension and Heart Failure Drugs Revenue, (US$, Mn), 2024-2032
Table 30. Menarini Group Company Summary
Table 31. Menarini Group Hypertension and Heart Failure Drugs Product Offerings
Table 32. Menarini Group Hypertension and Heart Failure Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Menarini Group Key News & Latest Developments
Table 34. Johnson & Johnson Company Summary
Table 35. Johnson & Johnson Hypertension and Heart Failure Drugs Product Offerings
Table 36. Johnson & Johnson Hypertension and Heart Failure Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Johnson & Johnson Key News & Latest Developments
Table 38. Lupin Company Summary
Table 39. Lupin Hypertension and Heart Failure Drugs Product Offerings
Table 40. Lupin Hypertension and Heart Failure Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Lupin Key News & Latest Developments
Table 42. Boehringer Ingelheim Company Summary
Table 43. Boehringer Ingelheim Hypertension and Heart Failure Drugs Product Offerings
Table 44. Boehringer Ingelheim Hypertension and Heart Failure Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Boehringer Ingelheim Key News & Latest Developments
Table 46. Novartis Company Summary
Table 47. Novartis Hypertension and Heart Failure Drugs Product Offerings
Table 48. Novartis Hypertension and Heart Failure Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Novartis Key News & Latest Developments
Table 50. Merck & Co Company Summary
Table 51. Merck & Co Hypertension and Heart Failure Drugs Product Offerings
Table 52. Merck & Co Hypertension and Heart Failure Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Merck & Co Key News & Latest Developments
Table 54. AstraZeneca Company Summary
Table 55. AstraZeneca Hypertension and Heart Failure Drugs Product Offerings
Table 56. AstraZeneca Hypertension and Heart Failure Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. AstraZeneca Key News & Latest Developments
Table 58. Pfizer, Inc Company Summary
Table 59. Pfizer, Inc Hypertension and Heart Failure Drugs Product Offerings
Table 60. Pfizer, Inc Hypertension and Heart Failure Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Pfizer, Inc Key News & Latest Developments
Table 62. Sanofi SA Company Summary
Table 63. Sanofi SA Hypertension and Heart Failure Drugs Product Offerings
Table 64. Sanofi SA Hypertension and Heart Failure Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Sanofi SA Key News & Latest Developments
Table 66. Dr. Reddy's Laboratories Company Summary
Table 67. Dr. Reddy's Laboratories Hypertension and Heart Failure Drugs Product Offerings
Table 68. Dr. Reddy's Laboratories Hypertension and Heart Failure Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Dr. Reddy's Laboratories Key News & Latest Developments
Table 70. Daiichi Sankyo Company Limited Company Summary
Table 71. Daiichi Sankyo Company Limited Hypertension and Heart Failure Drugs Product Offerings
Table 72. Daiichi Sankyo Company Limited Hypertension and Heart Failure Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Daiichi Sankyo Company Limited Key News & Latest Developments
List of Figures
Figure 1. Hypertension and Heart Failure Drugs Segment by Type in 2022
Figure 2. Hypertension and Heart Failure Drugs Segment by Application in 2022
Figure 3. Global Hypertension and Heart Failure Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Hypertension and Heart Failure Drugs Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Hypertension and Heart Failure Drugs Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hypertension and Heart Failure Drugs Revenue in 2022
Figure 8. By Type - Global Hypertension and Heart Failure Drugs Revenue Market Share, 2018-2032
Figure 9. By Application - Global Hypertension and Heart Failure Drugs Revenue Market Share, 2018-2032
Figure 10. By Type - Global Hypertension and Heart Failure Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Hypertension and Heart Failure Drugs Revenue Market Share, 2018-2032
Figure 12. By Application - Global Hypertension and Heart Failure Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Hypertension and Heart Failure Drugs Revenue Market Share, 2018-2032
Figure 14. By Region - Global Hypertension and Heart Failure Drugs Revenue Market Share, 2018-2032
Figure 15. By Country - North America Hypertension and Heart Failure Drugs Revenue Market Share, 2018-2032
Figure 16. US Hypertension and Heart Failure Drugs Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Hypertension and Heart Failure Drugs Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Hypertension and Heart Failure Drugs Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Hypertension and Heart Failure Drugs Revenue Market Share, 2018-2032
Figure 20. Germany Hypertension and Heart Failure Drugs Revenue, (US$, Mn), 2018-2032
Figure 21. France Hypertension and Heart Failure Drugs Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Hypertension and Heart Failure Drugs Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Hypertension and Heart Failure Drugs Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Hypertension and Heart Failure Drugs Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Hypertension and Heart Failure Drugs Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Hypertension and Heart Failure Drugs Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Hypertension and Heart Failure Drugs Revenue Market Share, 2018-2032
Figure 28. China Hypertension and Heart Failure Drugs Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Hypertension and Heart Failure Drugs Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Hypertension and Heart Failure Drugs Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Hypertension and Heart Failure Drugs Revenue, (US$, Mn), 2018-2032
Figure 32. India Hypertension and Heart Failure Drugs Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Hypertension and Heart Failure Drugs Revenue Market Share, 2018-2032
Figure 34. Brazil Hypertension and Heart Failure Drugs Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Hypertension and Heart Failure Drugs Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Hypertension and Heart Failure Drugs Revenue Market Share, 2018-2032
Figure 37. Turkey Hypertension and Heart Failure Drugs Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Hypertension and Heart Failure Drugs Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Hypertension and Heart Failure Drugs Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Hypertension and Heart Failure Drugs Revenue, (US$, Mn), 2018-2032
Figure 41. Menarini Group Hypertension and Heart Failure Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Johnson & Johnson Hypertension and Heart Failure Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Lupin Hypertension and Heart Failure Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Boehringer Ingelheim Hypertension and Heart Failure Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Novartis Hypertension and Heart Failure Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Merck & Co Hypertension and Heart Failure Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. AstraZeneca Hypertension and Heart Failure Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Pfizer, Inc Hypertension and Heart Failure Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Sanofi SA Hypertension and Heart Failure Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Dr. Reddy's Laboratories Hypertension and Heart Failure Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Daiichi Sankyo Company Limited Hypertension and Heart Failure Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
